Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jul 18, 2022

Dr. Michael Racke is the Medical Director at Quest Advanced Neurology, which is extending the options for neurologic diagnoses by looking for biomarkers in blood tests.

Michael explains, "And now, we're very much involved in developing plasma-based biomarkers to help diagnose Alzheimer's disease. Alzheimer's disease was a disorder that was initially diagnosed pathologically. You had to find the plaque and tangles in the brain at autopsy. Over the last 20 years, they've been able to show that with spinal fluid testing, you're able to identify changes in the cerebral spinal fluid suggestive of Alzheimer's disease. And now, we're also able to do that with a blood test."

"And for example, one of the ways that people were first able to do an evaluation for Alzheimer's disease in living people was to do a PET scan and actually demonstrate that you could do an imaging test that would show the beta amyloid plaques." 

"So, Alzheimer's disease was diagnosed by finding these plaques. The plaques are caused by aggregation of peptides of beta amyloid. And then the other thing was the neurofibrillary tangle. And that's actually the aggregation of a molecule called tao within neurons. And the combination of these two things results in the death of neurons and the loss of synapses, which eventually leads to the cognitive dysfunction that you see in Alzheimer's disease."

#QuestDiagnostics #Alzheimers #Dementia #Biomarkers #BloodBiomarkers #PlasmaBiomarkers #NeurologicalDiseases #LewyBodies #LewyBodyDementia

Download the transcript here

Quest Advanced